The Consortium for Cancer Implementation Science (CCIS) focuses on cancer control priorities, cross-collaboration, and innovative solutions in implementation science (IS). CCIS seeks to develop a new approach for the field to work together to address key challenges and identify and develop new areas of investigation toward advancing the IS agenda in cancer control.
CCIS DEVELOPMENT OF PUBLIC GOODS
To support the ongoing efforts of the Consortium for Cancer Implementation Science a collection of public goods, widely available tools and resources, have been developed by the action groups to address key challenges and advance the implementation science agenda in cancer.
Third Annual CCIS Meeting - October 6-7, 2021
The 2021 CCIS meeting focused on lessons learned in IS from COVID-19, and re-emerging and moving forward from the pandemic. The event featured a variety of presentations and discussion sessions, as well as pre-work to encourage more engagement and discussion during each virtual session meeting.
2020 CCIS Meeting
This meeting focused on short-term and long-term cancer control priorities, challenges, and opportunities during the COVID-19 pandemic. It also focused on synergies and gaps in the implementation science space across National Cancer Institute funded initiatives, and discussion on infrastructures for cross-collaboration. View outcomes from the second CCIS meeting.
2019 CCIS Meeting
This meeting focused on developing an expectation of how the field can work together to address key challenges and identify and develop key areas of research. These research areas require ongoing relationship and facilitation towards advancing the implementation science agenda in cancer control. View outcomes from the first CCIS meeting.